EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|9|1082-1097

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.9, 2011-11, pp. : 1082-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EphA2 as a target for ovarian cancer therapy

By Landen Charles N   Kinch Michael S   Sood Anil K  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1179-1187

Informa Healthcare

Access to resources Recommend Favorite

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

By Tandon Manish   Vemula Sai Vikram   Mittal Suresh K  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 31-51

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targeting of Lymphatics for Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 65-74

Bentham Science Publishers

Access to resources Recommend Favorite

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 5, Iss. 3, 2005-05 ,pp. : 149-157

Bentham Science Publishers

Access to resources Recommend Favorite

Valproic Acid in the Complex Therapy of Malignant Tumors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 361-379

Bentham Science Publishers

Access to resources Recommend Favorite